Only 3% of the cells had two copies of HER2. In an additional six patients with clinically defined HER2-negative breast cancers, only 5% of captured cells had ⩾4 copies of HER2 (Figure 3D). This evidence concerns the gene ERBB2 and breast carcinoma.